Бизнес · 18.05.19981 мин чтения
Agency Information Collection Activities; Orphan Drugs: Submission for OMB Review; Comment Request
Локальный автоматический перевод · Язык оригинального источника
Краткое содержание
The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA).